Evercore ISI Cuts Agilent Technologies (NYSE:A) Price Target to $126.00

Agilent Technologies (NYSE:AFree Report) had its target price lowered by Evercore ISI from $145.00 to $126.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has an in-line rating on the medical research company’s stock.

A number of other research analysts have also weighed in on A. UBS Group raised their price objective on Agilent Technologies from $130.00 to $155.00 and gave the company a neutral rating in a research report on Wednesday, February 28th. Citigroup raised their price objective on Agilent Technologies from $130.00 to $145.00 and gave the company a neutral rating in a research report on Wednesday, February 28th. Oppenheimer raised their price objective on Agilent Technologies from $67.00 to $90.00 and gave the company an outperform rating in a research report on Tuesday, March 26th. Barclays lifted their target price on Agilent Technologies from $125.00 to $135.00 and gave the stock an underweight rating in a report on Wednesday, April 10th. Finally, Robert W. Baird reduced their target price on Agilent Technologies from $147.00 to $136.00 and set an outperform rating for the company in a report on Thursday. One analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $137.19.

Check Out Our Latest Report on A

Agilent Technologies Stock Down 0.8 %

A stock opened at $130.41 on Thursday. Agilent Technologies has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a quick ratio of 2.04, a current ratio of 2.15 and a debt-to-equity ratio of 0.34. The firm has a market cap of $38.22 billion, a PE ratio of 30.83, a price-to-earnings-growth ratio of 3.73 and a beta of 1.13. The business has a 50 day moving average of $143.45 and a 200 day moving average of $137.32.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The company had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter last year, the company earned $1.27 EPS. The firm’s revenue for the quarter was down 8.4% on a year-over-year basis. On average, research analysts forecast that Agilent Technologies will post 5.2 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a $0.236 dividend. The ex-dividend date of this dividend is Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.72%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.22%.

Insider Transactions at Agilent Technologies

In related news, SVP Philip Binns sold 2,827 shares of Agilent Technologies stock in a transaction on Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the transaction, the senior vice president now directly owns 9,997 shares in the company, valued at $1,474,957.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, VP Rodney Gonsalves sold 4,828 shares of Agilent Technologies stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $149.00, for a total transaction of $719,372.00. Following the transaction, the vice president now directly owns 21,329 shares in the company, valued at $3,178,021. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Philip Binns sold 2,827 shares of Agilent Technologies stock in a transaction on Monday, March 25th. The shares were sold at an average price of $147.54, for a total value of $417,095.58. Following the transaction, the senior vice president now owns 9,997 shares in the company, valued at $1,474,957.38. The disclosure for this sale can be found here. Insiders have sold a total of 61,610 shares of company stock worth $9,220,333 in the last ninety days.

Institutional Investors Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. Livelsberger Financial Advisory bought a new stake in Agilent Technologies during the fourth quarter valued at about $26,000. MV Capital Management Inc. raised its holdings in Agilent Technologies by 120.7% during the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after acquiring an additional 105 shares during the period. VisionPoint Advisory Group LLC bought a new stake in Agilent Technologies during the fourth quarter valued at about $29,000. Rise Advisors LLC raised its holdings in Agilent Technologies by 527.8% during the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. bought a new stake in Agilent Technologies during the first quarter valued at about $34,000.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.